Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Psychopharmacology

• Publication date

  1998-01-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s002130050503PMID 9498724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with Yohimbine

  2004cited by this paper
• Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory

  2004cited by this paper
• Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam

  2004cited by this paper
• Activation of human prefrontal cortex during spatial and nonspatial working memory tasks measured by functional MRI.

  1996cited by this paper
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

  1996cited by this paper
• Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity.

  1995cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995influential reference
• Ketamine activates psychosis and alters limbic blood flow in schizophrenia

  1995cited by this paper
• NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study

  1994cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994influential reference
• m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.

  1993cited by this paper
• Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists

  1993cited by this paper
• Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists.

  1993cited by this paper
• Frontal lobes.

  1993cited by this paper
• Low‐dose midazolam antagonizes cerebral metabolic stimulation by ketamine in the pig

  1993cited by this paper
• Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.

  1993cited by this paper
• Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons.

  1992cited by this paper
• Effects of lorazepam on psychomotor performance: a comparison of independent-groups and repeated-measures designs.

  1992cited by this paper
• Negative symptoms and hypofrontality in chronic schizophrenia.

  1992cited by this paper
• NMDA receptor-mediated currents are prominent in the thalamocortical synaptic response before maturation of inhibition.

  1992cited by this paper
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

  1992influential reference
• Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists.

  1992cited by this paper
• Benzodiazepines in the treatment of schizophrenia: a review and reappraisal.

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991influential reference
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cited by this paper
• The chiral forms of ketamine as probes for NMDA receptor functions in humans

  1991cited by this paper
• Distribution of cortical neural networks involved in word comprehension and word retrieval.

  1991cited by this paper
• The behavioral pharmacology of NMDA receptor antagonists.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• The Structured Clinical Interview for DSM-III-R Dissociative Disorders: preliminary report on a new diagnostic instrument.

  1990cited by this paper
• The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm.

  1990cited by this paper
• Flumazenil in ketamine and midazolam anaesthesia

  1990cited by this paper
• Cortical circuits: Synaptic organization of the cerebral cortex. Structure, function and theory

  1990cited by this paper
• Regional distribution of [3H]MK-801 binding sites in the human brain.

  1989cited by this paper
• The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia.

  1989cited by this paper
• A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

  1989cited by this paper
• Total intravenous anesthesia for military surgery. A technique using ketamine, midazolam, and vecuronium

  1989cited by this paper
• Effects of diazepam on regional brain homovanillic acid following phencyclidine or delta 9-tetrahydrocannabinol.

  1989cited by this paper
• Ethanol inhibits NMDA-activated ion current in hippocampal neurons.

  1989cited by this paper
• Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium

  1988cited by this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.

  1988cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• [Midazolam and diazepam in ketamine anesthesia].

  1987cited by this paper
• Frontal lesions and sustained attention.

  1987cited by this paper
• Excitotoxity and the NMDA receptor

  1987cited by this paper
• Rating scales in research: the case of negative symptoms.

  1987cited by this paper
• Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines

  1987cited by this paper
• Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability.

  1987cited by this paper
• Effects of phencyclidine and ketamine on cardiovascular activity and temperature in the squirrel monkey.

  1987cited by this paper
• Serotonin function in anxiety

  1987cited by this paper
• An update on multiple personality disorder.

  1987cited by this paper
• Comparison of midazolam and diazepam to supplement total intravenous anaesthesia with ketamine for endoscopy

  1987cited by this paper
• Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

  1986cited by this paper
• The Perceptual Alteration Scale: a scale measuring dissociation.

  1986cited by this paper
• Involvement of N‐methyl‐D‐aspartate receptors in epileptiform bursting in the rat hippocampal slice.

  1986cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• Neurotransmitter regulation of anterior pituitary hormones.

  1985cited by this paper
• Scale for the assessment of reality testing: reliability, validity, and factorial invariance.

  1985influential reference
• Midazolam and diazepam in ketamine anaesthesia

  1984cited by this paper
• Subanesthetic doses of ketamine, diazepam, and nitrous oxide for adult outpatient sedation.

  1984influential reference
• Ketamine: behavioral effects of subanesthetic doses.

  1984cited by this paper
• Actions of benzodiazepines on the neuroendocrine system.

  1983cited by this paper
• Stereospecific binding of 3H-phencyclidine in brain membranes.

  1982cited by this paper
• The Influence of Droperidol, Diazepam, and Physostigmine on Ketamine‐induced Behavior and Brain Regional Glucose Utilization in Rat

  1982cited by this paper
• Role of the Frontal Lobes on an Attention Task: A Signal Detection Analysis

  1982cited by this paper
• Interaction Between Effects of Caffeine and Lorazepam in Performance Tests and Self‐Ratings

  1982cited by this paper
• Comparative Evaluation of Intravenous Agents for Rapid Sequence Induction—Thiopental, Ketamine, and Midazolam

  1982influential reference
• Ketamine--its pharmacology and therapeutic uses.

  1982cited by this paper
• Learning and Memory

  1982cited by this paper
• Reliabilities and intercorrelations of eight measures of proneness to psychosis.

  1982influential reference
• Low-dose ketamine and diazepam. Use as an adjunct to local anesthesia in an office operating room.

  1982cited by this paper
• Low dose intravenous infusion technique with ketamine

  1980cited by this paper
• Clinical processes and central dopaminergic activity in psychotic disorders.

  1980cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper
• Ketamine-induced changes in the GABA system of mouse brain.

  1980cited by this paper
• Ketamine sequelae. Evaluation of the ability of various premedicants to attenuate its psychic actions.

  1979influential reference
• Comparison of the actions of diazepam and lorazepam.

  1979cited by this paper
• SEROTONIN AND DOPAMINE METABOLITES IN BRAIN REGIONS AND CEREBROSPINAL FLUID OF A PRIMATE SPECIES: EFFECTS OF KETAMINE AND FLUPHENAZINE

  1979influential reference
• Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam.

  1978influential reference
• Phencyclidine and ketamine intoxication: a study of four populations of recreational users.

  1978cited by this paper
• The diagnosis and treatment of the PCP abuse syndrome.

  1978cited by this paper
• Phencyclidine and ketamine intoxication: a study of four populations of recreational users.

  1978cited by this paper
• Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam.

  1978cited by this paper
• Studies of drugs given before anaesthesia XXVI: lorazepam.

  1977cited by this paper
• Reduction of Psychotomimetic Side Effects of Ketalar® (Ketamine) by Rohypnol®(Flunitrazepam) A Randomized, Double‐Blind Trial

  1976influential reference
• Lorazepam Premedication: Lack of Recall and Relief of Anxiety

  1976cited by this paper
• Statistical Principles in Experimental Design, 2nd Edition.

  1973cited by this paper
• The taming of ketamine *

  1973cited by this paper
• INFLUENCE OF DIAZEPAM ON THE EMERGENCE REACTIONS FOLLOWING KETAMINE ANESTHESIA

  1973cited by this paper
• Influence of diazepam on the emergence reactions following ketamine anaesthesia

  1972cited by this paper
• Ketamine and the conscious mind

  1972cited by this paper
• Clinical studies of induction agents. 38. Effect of premedicants and supplements on ketamine anaesthesia.

  1971cited by this paper
• Clinical studies of induction agents. XXXVI: Ketamine.

  1970cited by this paper
• Some effects of an hallucinogenic drug (phencyclidine) on neurohumoral substances.

  1970cited by this paper
• Differential behavioral effects in frontal lobe disease

  1968cited by this paper
• Computational analysis of present-day American English

  1967cited by this paper
• Word fluency and brain damage

  1967cited by this paper
• Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581

  1966cited by this paper
• Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man

  1965cited by this paper

• Adverse Effects Associated With High-Dose Ketamine Infusions For Refractory Pain And Psychiatric Conditions

  2025influential citation
• A model to simulate human cardio-respiratory responses to ketamine analgesia

  2025cites this paper
• Eficácia da cetamina e esketamina no tratamento da depressão: revisão das evidências e perspectivas futuras

  2025cites this paper
• Ketamine in DUID cases in the greater Cologne area.

  2023cites this paper
• Ketamine Effects on Energy Metabolism, Functional Connectivity and Working Memory in Healthy Humans

  2023cites this paper
• Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments

  2023cites this paper
• A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population

  2022cites this paper
• Anaesthetics and time perception: A review

  2022cites this paper
• Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability

  2022cites this paper
• Risk Factors for the Development of Neuropsychiatric Adverse Effects in Ketamine-Treated Pain

  2022cites this paper
• Long-term safety of ketamine and esketamine in treatment of depression

  2022cites this paper
• Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review

  2021cites this paper
• An Update of Ketamine Illicit Use

  2021cites this paper
• Dissecting the neurobiology of linguistic disorganisation and impoverishment in schizophrenia.

  2021cites this paper
• The neurochemistry of hypnotic suggestion

  2021cites this paper
• Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

  2020cites this paper
• Looking into a Deluded Brain through a Neuroimaging Lens

  2020cites this paper
• Could Dietary Glutamate Play a Role in Psychiatric Distress?

  2019cites this paper
• Experimental Medicine Approaches in CNS Drug Development

  2019cites this paper
• Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression

  2018cites this paper
• Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists

  2018cites this paper
• Repeated Exposure to Ketamine in Adolescent Rats Results in Persistent Anxiety in the Adulthood

  2018cites this paper
• The Comprehension of Familiar and Novel Metaphoric Meanings in Schizophrenia: A Pilot Study

  2018cites this paper
• Ketamine for the treatment of addiction: Evidence and potential mechanisms

  2018cites this paper
• Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders

  2017influential citation
• Conversion factors for assessment of driving impairment after exposure to multiple benzodiazepines/z-hypnotics or opioids.

  2017cites this paper
• Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance Between Risks and Benefits

  2017cites this paper
• INTRANASALADMINISTRATION OF KETAMINE TO TREAT DEPRESSION

  2017cites this paper
• Prediction error, ketamine and psychosis: An updated model

  2016cites this paper
• Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

  2016cites this paper
• Translational research on cognitive and behavioural disorders in neurological and psychiatric diseases.

  2016cites this paper
• The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.

  2016cites this paper
• Leczenie zaburzeń funkcji poznawczych w schizofrenii Część II: Strategie farmakologiczne

  2016cites this paper
• Recherche translationnelle sur les troubles cognitifs et comportementaux dans les maladies neurologiques et psychiatriques

  2016cites this paper
• Ketamine’s Mechanism of Rapid Antidepressant Activity: Evidence Gleaned from Clinical Studies

  2016cites this paper
• Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains

  2016cites this paper
• The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models

  2016cites this paper
• A Pilot Study of the Pharmacogenetics of Ketamine-Induced Emergence Phenomena: A Dissertation

  2016cites this paper
• A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting.

  2016cites this paper
• Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability.

  2015cites this paper
• Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist

  2015cites this paper
• Intra‐ and postoperative low‐dose ketamine for adolescent idiopathic scoliosis surgery: a randomized controlled trial

  2015cites this paper
• Substance Abuse: Phencyclidine Use Disorders

  2015cites this paper
• Erratum to: a subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades

  2015cites this paper
• Optimizing the glutamatergic challenge model for psychosis, using S(+)-ketamine to induce psychomimetic symptoms in healthy volunteers

  2015cites this paper
• A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades

  2015cites this paper
• Psychiatric Morbidity in Ketamine Users Attending Counselling and Youth Outreach Services

  2015cites this paper
• Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications

  2014cites this paper
• Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.

  2014cites this paper
• Are Sexes Affected Differently by Ketamine? An Exploratory Study in Ketamine Users

  2014cites this paper
• ACMDCouncil on the Misuse of Drugs

  2014cites this paper
• Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

  2013influential citation
• Low‐dose ketamine as a potential adjuvant therapy for painful vaso‐occlusive crises in sickle cell disease

  2013cites this paper
• Cognitive Impairment in Schizophrenia: Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches toward understanding cognitive deficits

  2013cites this paper
• The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

  2013cites this paper
• Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans

  2013cites this paper
• The contribution of the brain response to ketamine to understanding the glutamatergic system and its role in human cognition

  2013cites this paper
• Descriptive Analysis of Postoperative Psychomimetic Side Effects of Subanesthetic Dose of Ketamine in Surgical Patients

  2013cites this paper
• Postoperative Pain and Other Acute Pain Syndromes

  2013cites this paper
• Contributions of Experimental Psychiatry to Research on the Psychosis Prodrome

  2013cites this paper
• Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans

  2012cites this paper
• Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

  2012cites this paper
• Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers

  2012cites this paper
• Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

  2012cites this paper
• Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway.

  2012cites this paper
• Glycine transport inhibitors in the treatment of schizophrenia.

  2012cites this paper
• Examination of ketamine-induced deficits in sensorimotor gating and spatial learning.

  2012cites this paper
• Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence

  2012cites this paper
• The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories

  2012cites this paper
• Alcohol and Glutamate Neurotransmission in Humans Implications for Reward, Dependence, and Treatment

  2012cites this paper
• Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

  2011influential citation
• A Genome-Wide Analysis of Liberal and Conservative Political Attitudes

  2011cites this paper
• Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia

  2011cites this paper
• Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference

  2011cites this paper
• Ketamine perturbs perception of the flow of time in healthy volunteers

  2011cites this paper
• A role for glutamate in subjective response to smoking and its action on inhibitory control

  2011cites this paper
• Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.

  2011cites this paper
• Pharmacological Models of Psychosis - Amphetamine and Ketamine

  2011cites this paper
• Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

  2011cites this paper
• The discriminative stimulus effects of midazolam are resistant to modulation by morphine, amphetamine, dizocilpine, and γ-butyrolactone in rhesus monkeys

  2011cites this paper
• Alcohol-Induced Blackout: Phenomenology, Biological Basis, and Gender Differences

  2010cites this paper
• Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

  2010cites this paper
• Behandlung kognitiver Defizite bei Schizophrenie

  2010cites this paper
• Quantifying the Psychological Effects of Ketamine: From Euphoria to the k-Hole

  2010cites this paper
• Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.

  2010cites this paper
• Taming the Ketamine Tiger

  2010cites this paper
• esearch report-methyl-d-aspartate ( NMDA ) receptor dysfunction or dysregulation : The final ommon pathway on the road to schizophrenia ?

  2010cites this paper
• Behandlung kognitiver Defizite bei Schizophrenie. Teil II: Pharmakologische Strategien

  2010cites this paper
• Acute and Chronic Effects of Ketamine on Semantic Priming: Modeling Schizophrenia?

  2009cites this paper
• Handbook of neurochemistry and molecular neurobiology, schizophrenia

  2009cites this paper
• Semantic priming, schizophrenia and the ketamine model of psychosis

  2009cites this paper
• The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?

  2009cites this paper
• Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia

  2009cites this paper
• The Early and Delayed Analgesic Effects of Ketamine After Total Hip Arthroplasty: A Prospective, Randomized, Controlled, Double-Blind Study

  2009cites this paper
• Differential Involvement of Glutamatergic Mechanisms in the Cognitive and Subjective Effects of Smoking

  2009cites this paper
• A subacute behavioral disorder in a female adolescent. Autoimmune anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

  2009cites this paper
• Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.

  2008cites this paper
• Chapter 14 – Postoperative Pain and Other Acute Pain Syndromes

  2008cites this paper
• Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance.

  2008cites this paper
• Chronic ketamine use and psychotic symptomatology

  2008cites this paper